MARKET

AGEN

AGEN

Agenus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.020
+0.090
+2.29%
Pre Market: 4.030 +0.01 +0.25% 08:00 07/02 EDT
OPEN
4.000
PREV CLOSE
3.930
HIGH
4.055
LOW
3.885
VOLUME
1.53M
TURNOVER
--
52 WEEK HIGH
4.785
52 WEEK LOW
1.820
MARKET CAP
682.50M
P/E (TTM)
-3.2577
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AGEN stock price target is 5.50 with a high estimate of 6.00 and a low estimate of 5.00.

EPS

AGEN News

More
What Makes Agenus (AGEN) a Strong Momentum Stock: Buy Now?
Zacks · 5d ago
U.S. debut on horizon for iTeos Therapeutics
Seeking Alpha - Article · 6d ago
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?
Is (AGEN) Outperforming Other Medical Stocks This Year?
Zacks · 6d ago
Agenus' Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Agenus.
Zacks · 6d ago
Cramer Weighs In On Halliburton, AstraZeneca And More
Benzinga · 06/24 21:53
Cramer Weighs In On Halliburton, AstraZeneca And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said that Taiwan Semiconductor Mfg. Co. Ltd. (NYSE: TSM) is a great stock.
Benzinga · 06/24 20:53
The Charts of Agenus Need More Development
TheStreet.com · 06/24 17:35
Cramer's lightning round: Two thumbs up for AstraZeneca
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 06/23 23:13

Industry

Biotechnology & Medical Research
-0.32%
Pharmaceuticals & Medical Research
+0.20%

Hot Stocks

Symbol
Price
%Change

About AGEN

Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage, AutoSynVax and PhosPhoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company's discovery pipeline includes a range of checkpoint modulating (CPM) antibodies. The Company's vaccine platforms include its heat shock protein (HSP)-based Prophage vaccine candidates, and its synthetic vaccine candidates, ASV and PSV.
More

Webull offers kinds of Agenus Inc stock information, including NASDAQ:AGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGEN stock methods without spending real money on the virtual paper trading platform.